BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9059350)

  • 1. Topoisomerase II alpha mRNA and tumour cell proliferation in non-Hodgkin's lymphoma.
    Lohri A; Reuter J; Gudat F; Herrmann R
    J Clin Pathol; 1997 Jan; 50(1):22-6. PubMed ID: 9059350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of DNA topoisomerase IIalpha expression provides independent prognostic information in non-Hodgkin's lymphomas.
    Korkolopoulou P; Angelopoulou M; Siakantari M; Mitropoulos F; Vassilakopoulos T; Zorzos H; Rassidakis G; Androulaki A; Patsouris E; Kittas C; Davaris P; Pangalis GA
    Histopathology; 2001 Jan; 38(1):45-53. PubMed ID: 11135046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
    Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
    Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of topotecan and etoposide for non-Hodgkin lymphoma: correlation of topoisomerase-DNA complex formation with clinical response.
    Kancherla RR; Nair JS; Ahmed T; Durrani H; Seiter K; Mannancheril A; Tse-Dinh YC
    Cancer; 2001 Feb; 91(3):463-71. PubMed ID: 11169927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.
    Giaccone G; van Ark-Otte J; Scagliotti G; Capranico G; van der Valk P; Rubio G; Dalesio O; Lopez R; Zunino F; Walboomers J
    Biochim Biophys Acta; 1995 Dec; 1264(3):337-46. PubMed ID: 8547322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclin A and topoisomerase IIalpha of oligodendrogliomas is correlated with tumour grade, MIB-1 labelling index and survival.
    Park SH; Suh YL
    Histopathology; 2003 Apr; 42(4):395-402. PubMed ID: 12653952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.
    Lynch BJ; Guinee DG; Holden JA
    Hum Pathol; 1997 Oct; 28(10):1180-8. PubMed ID: 9343325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of topoisomerase targeting drugs on non-Hodgkin's lymphoma and leukemia. Correlation of clinical and cell culture studies.
    Nair JS; Kancherla R; Seiter K; Traganos F; Tse-Dinh YC
    Ann N Y Acad Sci; 2000; 922():326-9. PubMed ID: 11193914
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.
    Winther TL; Torp SH
    PLoS One; 2017; 12(3):e0172316. PubMed ID: 28301542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
    Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
    Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of topoisomerase II alpha, Ki-67 and p53 in early stage laryngeal carcinomas not featuring vocal cord fixation.
    Horibe Y; Murakami M; Komori K; Imaeda Y; Kasahara M
    APMIS; 2000 Oct; 108(10):689-96. PubMed ID: 11200824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical evaluation of topoisomerase IIalpha as proliferation factor in gastric lymphoma].
    Ferariu D; Danciu M; Ciobanu D; Zugun F; Florea N; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):738-43. PubMed ID: 20201262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
    Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
    Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphoma.
    Doussis-Anagnostopoulou IA; Vassilakopoulos TP; Thymara I; Korkolopoulou P; Angelopoulou MK; Siakantaris MP; Kokoris SI; Dimitriadou EM; Kalpadakis C; Matzouranis M; Kaklamanis L; Panayiotidis P; Kyrtsonis MC; Androulaki A; Patsouris E; Kittas C; Pangalis GA
    Clin Cancer Res; 2008 Mar; 14(6):1759-66. PubMed ID: 18347177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
    Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
    Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
    Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
    Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
    Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
    J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining for DNA topoisomerase II in non-Hodgkin's lymphomas.
    Holden JA; Perkins SL; Snow GW; Kjeldsberg CR
    Am J Clin Pathol; 1995 Jul; 104(1):54-9. PubMed ID: 7611182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.